Azatadine: Difference between revisions
Kiran Singh (talk | contribs) No edit summary |
Kiran Singh (talk | contribs) No edit summary |
||
| Line 44: | Line 44: | ||
| StdInChIKey = SEBMTIQKRHYNIT-UHFFFAOYSA-N | | StdInChIKey = SEBMTIQKRHYNIT-UHFFFAOYSA-N | ||
}} | }} | ||
__Notoc__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Azatadine''' ('''Optimine''') is a [[first-generation antihistamine]] and [[anticholinergic]] that was launched [[Schering-Plough]] in 1973.<ref>{{cite pmid|8795241}}</ref><ref>{{cite pmid|1982614}}</ref><ref>{{cite pmid|1968324}}</ref> | '''Azatadine''' ('''Optimine''') is a [[first-generation antihistamine]] and [[anticholinergic]] that was launched [[Schering-Plough]] in 1973.<ref>{{cite pmid|8795241}}</ref><ref>{{cite pmid|1982614}}</ref><ref>{{cite pmid|1968324}}</ref> | ||
| Line 59: | Line 63: | ||
{{Antihistamines}} | {{Antihistamines}} | ||
[[Category:Piperidines]] | [[Category:Piperidines]] | ||
[[Category:H1 receptor antagonists]] | [[Category:H1 receptor antagonists]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 12:57, 13 April 2015
 | |
| Clinical data | |
|---|---|
| Trade names | Optimine |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy category |
|
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C20H22N2 |
| Molar mass | 290.402 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
|
WikiDoc Resources for Azatadine |
|
Articles |
|---|
|
Most recent articles on Azatadine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Azatadine at Clinical Trials.gov Clinical Trials on Azatadine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Azatadine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Azatadine Discussion groups on Azatadine Directions to Hospitals Treating Azatadine Risk calculators and risk factors for Azatadine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Azatadine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Azatadine (Optimine) is a first-generation antihistamine and anticholinergic that was launched Schering-Plough in 1973.[1][2][3]
It was patented in 1967.[4]
- It is a predecessor to loratidine, albeit lacking the chlorine atom. Also, it is N-methyl instead of carboethoxyamido.
See also
References
- ↑ PMID 8795241 (PMID 8795241)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 1982614 (PMID 1982614)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 1968324 (PMID 1968324)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ Azatadine, Villani, F. J.; Caldwell, W. U.S. Patent 3,326,924 (1967).